effect of Serum Magnesium levels in Renal transplant recipients
Not Applicable
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2019/09/021043
- Lead Sponsor
- DEPARTMENT OF ANAESTHESIOLOGY PAIN AND PERIOPERATIVE MEDICINE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients aged 18-60 years
2.End stage renal disease
3.Either sex
4.ASA physical status II & III
Exclusion Criteria
1.Patient refusal
2.Liver disease
3.Hypermagnesemia > 2.7 mmol/l
4.Hyperkalemia > 5.5 mmol/l
5.Severe cardiopulmonary compromise
6.Diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine Preoperative and postoperative magnesium levels in the two study groups.Timepoint: To determine Preoperative and postoperative magnesium levels in the two study groups.
- Secondary Outcome Measures
Name Time Method i.To compare electrolytes, acid base balance, serum lactate and graft function in the two groups . Graft function will be assessed by immediate brisk diuresis after reperfusion and serum creatinine on day 1,2 10 and after 1 month. <br/ ><br>ii.To observe the incidence of adverse events: Delayed graft function and Cardiorespiratory compromise <br/ ><br>Timepoint: from intraoperative to 1 month after the surgery